Research location

Taipei

Taiwan, Taiwan

Published trials99

Site observations119

Linked trials published99

Page2 / 2

Research activity in Taipei

Taiwan, Taiwan

CureCurrent currently publishes aggregate city-level research activity for this location: 99 trials and 119 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Taipei

99 linked trials · page 2 of 2

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K ActivationNCT01572727 · 2012-08-01 · 1 site observation

A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast CancerNCT01617668 · 2012-08-01 · 1 site observation

The Roles of Age, Comorbidity, and Telomere Length in Lung Cancer Treatment and PrognosisNCT01963533 · 2012-08-01 · 1 site observation

Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive HypertensionNCT01681576 · 2012-08-01 · 2 site observations

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential HypertensionNCT01615198 · 2012-08-01 · 2 site observations

Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to AmlodipineNCT01663233 · 2012-08-01 · 2 site observations

Illness Crisis Adapting in Early or Middle Phase of Patient With Chronic Disease: Study of Meta-cognition ModelNCT01964612 · 2012-07-01 · 1 site observation

The Effect of Extract of Green Tea on Obese Women and Obese Related Hormone PeptidesNCT02147041 · 2012-05-01 · 1 site observation

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast CancerNCT01528345 · 2012-04-01 · 1 site observation

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With HypertensionNCT01570686 · 2012-04-01 · 2 site observations

Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in T1DMNCT01727661 · 2012-02-01 · 1 site observation

Quality Study of Anesthetic Technique on Breast Cancer SurgeryNCT01499836 · 2012-01-01 · 1 site observation

Feasibility and Effectiveness of Telehealth in Patients With Chronic Obstructive Pulmonary Disease in TaiwanNCT01724684 · 2011-12-01 · 1 site observation

The Hemodynamic Effects During Sustained Low-efficiency Dialysis Versus Continuous Veno-venous Hemofiltration for Patients With Intracranial Hypertension in a Cross Over StudyNCT01781585 · 2011-08-01 · 1 site observation

Gene Promoter DNA Methylations and Their Relationships With Endophenotypes in Patients With SchizophreniaNCT01362478 · 2011-08-01 · 1 site observation

18F-FLT Positron Emission Tomography and Magnetic Resonance Imaging of the BreastNCT01956890 · 2011-06-01 · 1 site observation

Early Diagnosis of Postoperative Acute Renal Failure-using Biomarker to Predict Outcome of Cardiac Surgery Associated Acute Kidney InjuryNCT01503710 · 2011-06-01 · 1 site observation

Evaluation of the Effects of Chinese Medical Treatment on Leucopenia After Chemotherapy in Breast Cancer PatientsNCT01359501 · 2011-05-01 · 1 site observation

MBCGT and Psycho-physiological Stress Regulation Group for Depression and Psycho-physiological Stress PatientNCT01894932 · 2011-04-01 · 1 site observation

Thoracoscopic Lobectomy Using Nonintubated Anesthesia Versus Intubated General Anesthesia for Lung Cancer PatientsNCT01533233 · 2011-02-01 · 1 site observation

A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential HypertensionNCT01256411 · 2010-11-01 · 3 site observations

Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderNCT01255787 · 2010-11-01 · 1 site observation

ß-Cell Function and Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients With Moderate HyperglycemiaNCT01717911 · 2010-09-01 · 1 site observation

Efficacy and Safety of LCZ696 Compared to Placebo in Patients With Essential HypertensionNCT01193101 · 2010-08-01 · 3 site observations

Obesity-related Genes in Taiwanese Undergoing Weight LossNCT01684280 · 2010-06-01 · 1 site observation

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)NCT01104584 · 2010-05-01 · 1 site observation

Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With RadiotherapyNCT01142479 · 2010-05-01 · 1 site observation

Accomplices of Insulin Resistance in Prehypertension: Aldosterone?NCT01112007 · 2010-04-01 · 1 site observation

Evaluation of Effects of Exercise Training and ARB in DM PatientsNCT01053026 · 2009-12-01 · 1 site observation

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 2 site observations

Comparing Treatment Efficacy With HD/MD Flu Plus Sal in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01131806 · 2009-12-01 · 1 site observation

A Trial of EVL\GVS Alone vs. EVL\GVS Combined PropranololNCT01298284 · 2009-10-01 · 1 site observation

Obesity and Clinical Presentation of HyperandrogenismNCT01114633 · 2009-06-01 · 1 site observation

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart FailureNCT00894387 · 2009-05-01 · 1 site observation

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart FailureNCT00853658 · 2009-03-01 · 2 site observations

Exacerbation StudyNCT00845728 · 2009-03-01 · 1 site observation

Effects of Different Exercise Training Dose on Exercise Performance and Noninvasively Estimated Muscle Oxygen Extraction in Diabetic Postmenopausal WomenNCT00905203 · 2009-02-01 · 1 site observation

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerNCT01019798 · 2009-01-01 · 1 site observation

Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung TumorsNCT01089894 · 2008-08-01 · 1 site observation

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation TherapyNCT00751543 · 2008-01-01 · 1 site observation

The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate CancerNCT01089881 · 2008-01-01 · 1 site observation

Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron OverloadNCT00600938 · 2007-11-01 · 1 site observation

Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases)NCT00549757 · 2007-10-01 · 2 site observations

A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)NCT00558636 · 2007-09-01 · 1 site observation

Efficacy and Safety of LCZ696A in Patients With Essential HypertensionNCT00549770 · 2007-09-01 · 2 site observations

Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular SurgeriesNCT01075347 · 2007-03-01 · 1 site observation

Comparisons of Serologic Response of Early SyphilisNCT01944358 · 2007-01-01 · 2 site observations

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast CancerNCT01025349 · 2005-01-01 · 1 site observation

A Study to Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent DiabetesNCT01706211 · 1998-10-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.